CXCL9 is a dual‑role biomarker in colorectal cancer linked to mitophagy and modulated by ALKBH5.

Mol Med Rep · 2025 · PMC12076282 · PMID 40341964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

the present study conducted an analysis of CXCL9 expression at different pathologic stages and the results showed a trend of initial increase followed by decrease during cancer progression.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.